Rani Therapeutics Holdings Inc

RANINASDAQ · USD
0.86USD0.00 (+1.23%)
2310

Rani Therapeutics Holdings Inc (RANI) Straddle

RANI straddle scan found 1 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 100.0%.

Read more

Trading a RANI straddle lets you take a pure volatility position on Rani Therapeutics Holdings Inc without committing to a direction. Rani Therapeutics Holdings Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate RANI straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on RANI profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Rani Therapeutics Holdings Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the RANI straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes.

The company was incorporated in 2012 and is headquartered in San Jose, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the RANI straddle is the cleanest expression of that view. Our scanner prices every RANI straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a RANI straddle into a catalyst or short a RANI straddle to harvest decay, the options straddle setups that matter are all in one place.

Apr 16, 20272.50$1.83210100%100.0%$4.33$0.682

As of September 18, 2026

Find the right straddle before volatility moves

Track RANI straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial